[Behavior of the progessive antithrombin during long-term anticoagulant therapy (Vitamin K antagonists)].
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000378:metabolism*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001593:Benzyl Compounds / Q000008:administration & dosage; D001780:Blood Coagulation Tests; D003374:Coumarins / Q000008:administration & dosage; D004617:Embolism / Q000188:drug therapy; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D000991:Antithrombins; D001593:Benzyl Compounds; D003374:Coumarins; D014812:Vitamin K
Das Verhalten des Progressiv-Antithrombins unter Langzeittherapie mit Antikoagulantien (Vitamin-K-Antagonisten.